Takeda Pharmaceutical (TAK) FCF Margin Growth (3y) (2021 - 2026)
Powered by 
Analysis
Takeda Pharmaceutical (TAK) FCF Margin Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 1,461.00 |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | -2,596.00 |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 874.00 |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 982.00 |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 1,832.00 |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 1,733.00 |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | -176.00 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 1,592.00 |
| 10 | Takeda Pharmaceutical | 2.61 Bn | -3.19 Bn | 5.10 Bn | 180.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 180.00 |
| Mar 31, 2026 | -220.00 |
| Dec 31, 2025 | 36.00 |
| Sep 30, 2025 | -4,896.00 |
| Jun 30, 2025 | 1,080.00 |
| Mar 31, 2025 | 161.00 |
| Dec 31, 2024 | -85.00 |
| Sep 30, 2024 | -2,187.00 |
| Jun 30, 2024 | -186.00 |
| Mar 31, 2024 | -3,000.00 |
| Dec 31, 2023 | -1,057.00 |
| Sep 30, 2023 | -1,221.00 |
| Jun 30, 2023 | -801.00 |
| Mar 31, 2023 | -946.00 |
| Sep 30, 2022 | 1,468.00 |
| Jun 30, 2022 | -475.00 |
| Mar 31, 2022 | -3,292.42 Bn |
| Dec 31, 2021 | 2,029.00 |
| Sep 30, 2021 | 917.00 |
| Jun 30, 2021 | 736.00 |